Literature DB >> 11486051

t(15;17) Reverse transcription-polymerase chain reaction with alternative splicing.

R K Rolston1, J A Kant.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11486051      PMCID： PMC1906956          DOI： 10.1016/S1525-1578(10)60661-7

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.568


× No keyword cloud information.
  7 in total

Review 1.  Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia.

Authors:  F Lo Coco; D Diverio; B Falini; A Biondi; C Nervi; P G Pelicci
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

2.  15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia.

Authors:  J D Rowley; H M Golomb; C Dougherty
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

3.  Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse.

Authors:  W Huang; G L Sun; X S Li; Q Cao; Y Lu; G S Jiang; G S Jang; F Q Zhang; J R Chai; Z Y Wang; S Waxman
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

Review 4.  Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.

Authors:  L Vahdat; P Maslak; W H Miller; A Eardley; G Heller; D A Scheinberg; R P Warrell
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

5.  Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party.

Authors:  D Grimwade; K Howe; S Langabeer; L Davies; F Oliver; H Walker; D Swirsky; K Wheatley; A Goldstone; A Burnett; E Solomon
Journal:  Br J Haematol       Date:  1996-09       Impact factor: 6.998

6.  Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.

Authors:  R E Gallagher; Y P Li; S Rao; E Paietta; J Andersen; P Etkind; J M Bennett; M S Tallman; P H Wiernik
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

7.  Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia.

Authors:  P P Pandolfi; M Alcalay; M Fagioli; D Zangrilli; A Mencarelli; D Diverio; A Biondi; F Lo Coco; A Rambaldi; F Grignani
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.